Perspectives on Newly Diagnosed Myeloma Treatment and Emerging Challenges
This commentary explores new challenges in the management of newly diagnosed multiple myeloma and strategies for sustaining improvements in patient outcomes. We highlight the need for risk-adapted approaches, the potential future incorporation of T cell-redirecting immunotherapies in first-line treatment, and the challenge of access to care.
Authors
- Cyrille Touzeau (ORCID: https://orcid.org/0000-0003-0275-2575)
- Philippe Moreau (ORCID: https://orcid.org/0000-0003-1780-8746)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Hotel Dieu Hospital (CA)
- Hôtel-Dieu de Paris (FR)
- Nantes Université (FR)
Publication Details
- Journal
- Blood Cancer Discovery
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1158/2643-3230.bcd-25-0280
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00